A two-step toward personalized therapies for prostate cancer

Related Experiment Video

Updated: Jun 4, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Andrew S Goldstein1, Yang Zong, Owen N Witte

  • 1Molecular Biology Institute, University of California, Los Angeles, CA 90095, USA.

Science Translational Medicine
|March 4, 2011
PubMed

Insights

This study identifies SPINK1 as a therapeutic target in a subset of prostate tumors. Targeting SPINK1 and potentially its interaction with epidermal growth factor receptor may offer new treatment strategies for prostate cancer.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Prostate tumors can be classified by genetic alterations like ETS gene rearrangements or SPINK1 overexpression.
  • SPINK1 (a secreted serine protease inhibitor) is implicated in prostate tumorigenesis.

Purpose of the Study:

  • To investigate SPINK1 as a therapeutic target in prostate tumors.
  • To explore potential interactions of SPINK1 with other molecular targets.

Main Methods:

  • Analysis of genetic alterations in prostate tumors.
  • Investigation of SPINK1 protein function and interactions.

Main Results:

  • Evidence supports targeting SPINK1 in the SPINK1+/ETS⁻ prostate tumor subset.
  • A potential interaction between SPINK1 and epidermal growth factor receptor was identified.

Conclusions:

  • SPINK1 is a viable therapeutic target for a specific subset of prostate cancers.
  • Inhibition of SPINK1 and/or epidermal growth factor receptor could be a novel therapeutic strategy.

More Related Videos

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization07:34

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Published on: November 17, 2023

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...